NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹638 Cr | ₹486 Cr | ₹606 Cr | ₹604 Cr | ₹1,030 Cr |
What is the latest Short Term Loans and Advances ratio of NATCO PHARMA ?
Year | Short Term Loans and Advances |
---|---|
Mar2024 | ₹638 Cr |
Mar2023 | ₹486 Cr |
Mar2022 | ₹606 Cr |
Mar2021 | ₹604 Cr |
Mar2020 | ₹1,030 Cr |
How is Short Term Loans and Advances of NATCO PHARMA Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2024 | ₹638 Cr | 31.43 | |
Mar2023 | ₹486 Cr | -19.89 | |
Mar2022 | ₹606 Cr | 0.41 | |
Mar2021 | ₹604 Cr | -41.39 | |
Mar2020 | ₹1,030 Cr | - |
Compare Short Term Loans and Advances of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹14,567.1 Cr | -4.4% | 0.9% | -17.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹427,406.0 Cr | -2.7% | 3.9% | 19.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,113.0 Cr | 1% | 8.5% | 55.3% | Stock Analytics | |
CIPLA | ₹121,869.0 Cr | -2.6% | 3.9% | 6.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,345.0 Cr | -0.7% | 2.5% | 22.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,801.0 Cr | -1.9% | 0.9% | -7.8% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | -4.4% |
0.9% |
-17.9% |
SENSEX | 0.6% |
6.2% |
8.4% |
You may also like the below Video Courses